NOTE: The IAPAC-Lancet HIV Commission on the Future of Urban HIV Responses will be officially released on July 22, 2024, on the eve of the AIDS 2024 conference in Munich, Germany. A link to the Commission report will be available on this webpage at 2:00 pm CEST, Monday, July 22, 2024.
About the Commission
The IAPAC-Lancet HIV Commission on the Future of Urban HIV Responses’ mission was to document and summarize experiences and best practices in urban HIV responses, reflecting the diversity of the world’s urban settings and their health successes and challenges in HIV prevention, care, and treatment. Additionally, the Commission examined structural and other barriers to achieving Sustainable Development Goal (SDG) 3.3 of ending AIDS as a public health threat, and SDG 10 of making cities safe, inclusive, and resilience. The Commission also examined lessons learned by the COVID-19 pandemic, notably in relation to innovative approaches cities implemented to maintain a continuity of HIV and other health services through several waves of COVID-19 infections.
The IAPAC-Lancet HIV Commission was structured into seven thematic sections:
- Centering Equity in Urban HIV Responses
- Realizing the Right to Health in Urban Settings
- Addressing Urban Social Determinants of Health
- Addressing Syndemic Conditions and Comorbidities in Urban Settings
- Building Urban Health Systems Resilience
- Implementing Urban Data-Driven Accountability Frameworks
- Modeling an End of Urban HIV Epidemics
The Commission was comprised of representatives from constituencies engaged in urban HIV responses in across the global Fast-Track Cities network: public health officials, clinical and service providers, and community representatives. Commissioners were advised by content experts and key opinion leaders in city government administration, health systems, health service delivery, health financing, epidemiology, modeling, human rights, social determinants, implementation science, behavioral and social sciences, and community engagement.
Commissioners
| José M. Zuniga, PhD, MPH Commission Chair International Association of Providers of AIDS Care (IAPAC) Washington, DC, USA |
 |
| Shrikala Acharya, MD Mumbai District AIDS Control Society Mumbai, India |
 |
| Angeli Achrekar, DrPH UNAIDS Geneva, Switzerland |
|
| Jane Anderson, MBBS, PhD Homerton University London, UK |
 |
| Solange Baptiste, MS ITPC Global Johannesburg, South Africa |
|
| Geoffrey Barrow, MBBS, PhD, MSc University of the West Indies Kingston, Jamaica |
 |
| Josip Begovac, MD, DPhil University of Zagreb Zagreb, Croatia |
 |
| Elizabeth Bukusi, MBChB, MD, MPH, PhD Kenya Medical Research Institute Nairobi, Kenya |
 |
| Amanda Castel, MD, MPH George Washington University Washington, DC, USA |
 |
| Erika Castellanos Global Action for Trans Equality (GATE) Amsterdam, The Netherlands |
 |
| Jorge Cestou, PhD, MBA Chicago Department of Health Chicago, IL, USA |
 |
| Gertrude Chirambo Blantyre City Council Blantyre, Malawi |
|
| Jeffrey Crowley, MPH Georgetown University Washington, DC, USA |
|
| Nikos Dedes Positive Voice Athens, Greece |
|
| Lucica Ditiu, MD Stop TB Partnership Geneva, Switzerland |
|
| Dázon Dixon Diallo, MPH, DHL Sister Love Atlanta, USA |
 |
| Meg Doherty, MD, MPH, PhD World Health Organization (WHO) Geneva, Switzerland |
 |
| Chris Duncombe, MD International Association of Providers of AIDS Care (IAPAC) Washington, DC, USA |
|
| Adriana Durán, MD Ministry of Health, Buenos Aires Buenos Aires, Argentina |
|
| Donna Futterman, MD Albert Einstein College of Medicine New York, NY, USA |
 |
| Anisha Gandhi, PhD, MPH NYC Department of Health and Mental Hygiene New York City, USA |
 |
| Shannon Hader, MD, MPH American University Washington, DC, USA |
 |
| Chyrol Kounkeu Cameroonian Association for the Development and Empowerment of Vulnerable People Yaoundé, Cameroon |
| Fran Lawless, MHA Mayor’s Office of Health Policy New Orleans, USA |
 |
| Jeffrey Lazarus, PhD, MIH, MA University of Barcelona Barcelona, Spain |
 |
| Sabine Lex Aidshilfe Wien Vienna, Austria |
|
| Carlos Lobos, MS Chile Positivo Santiago, Chile |
 |
| Alice Pedro Magaia de Abreau, MD, MPH Maputo City Council Maputo, Mozambique |
 |
| Nombulelo Magula, MBChB, MSc, PhD University of KwaZulu-Natal Durban, South Africa |
 |
| Kenneth Mayer, MD Fenway Institute Boston, MA, USA |
 |
| Maria Mejia The Well Project Miami, FL, USA |
|
| H. Rodrigo Moheno Fundacion Mexico Vivo Mexico City, Mexico |
 |
| Antonella d’Arminio Monforte, MD University of Milan Milan, Italy |
|
| Mónica Morán-Arribas, MD, MPH Ministry of Health, Madrid Madrid, Spain |
 |
| Daniel Nagel FAQ Health Hamburg, Germany |
 |
| Robert Ndugwa, PhD UN-Habitat Nairobi, Kenya |
 |
| Carol Ngunu, MD, MSc Nairobi City County Department of Health Nairobi, Kenya |
 |
| Nicoletta Policek, PhD European AIDS Treatment Group (EATG) Belgium, Brussels |
 |
| Midnight Poonkasetwattana, MSc APCOM Bangkok, Thailand |
 |
| Corey Prachniak, JD, MPH CentreLink Boston, MA, USA |
|
| Maria Prins, PhD Academic Medical Center Amsterdam, The Netherlands |
|
| Amara Quesada Action for Health Initiatives Quezon City, Philippines |
|
| Sindhu Ravishankar, MPhil Fast-Track Cities Institute Washington, DC, USA |
|
| Olga Rudnieva Superhumans Center Kyiv, Ukraine |
 |
| Simon Ruth, MSS Thorne Harbour Health Melbourne, Australia |
|
| Jorge Saavedra, MD, MSc AHF Global Public Health Institute Miami, FL, USA |
 |
| Lance Toma, MSW San Francisco Community Health Center San Francisco, CA, USA |
|
| Lucy Wanjiku Positive Young Women’s Voices Nairobi, Kenya |
 |
| Brian Williams, PhD SACEMA Geneva, Switzerland |
 |
